ERIS vs RELIANCE
Head-to-head DCF comparison · Eris Lifesciences Limited vs Reliance Industries
Model Favors
RELIANCE shows a larger model margin of safety
Leads on 3 of 4model metrics · not investment advice
ERIS
Eris Lifesciences Limited
Pharma
₹1,405
Data LimitedRELIANCE
Reliance Industries
Oil & Gas
₹1,293
Near Fair Value| Metric | ERIS | RELIANCE |
|---|---|---|
| Verdict | Data Limited | Near Fair Value |
| YieldIQ Score | 50/100 | 67/100 |
| Fair Value | ₹744 | ₹1,535 |
| Current Price | ₹1,405 | ₹1,293 |
| Discount to FV | -47.0% | +18.8% |
| Moat | Narrow | Moderate |
| Piotroski F-Score | 6/9 | 4/9 |
| ROE | 15.9% | 8.9% |
| Debt / Equity | 0.60 | 0.37 |
| EV / EBITDA | 19.6× | 9.8× |
| Market Cap | ₹19,463 Cr | ₹17.50 Lakh Cr |
Run the full interactive analysis
DCF sliders, sensitivity tables, peer screens, watchlists — free to start.
Sign up free →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst.